Home
Scholarly Works
CYP2C19 Genetic Testing Should Not Be Done in All...
Journal article

CYP2C19 Genetic Testing Should Not Be Done in All Patients Treated With Clopidogrel Who Are Undergoing Percutaneous Coronary Intervention

Authors

Paré G; Eikelboom JW; Sibbing D; Bernlochner I; Kastrati A

Journal

Circulation Cardiovascular Interventions, Vol. 4, No. 5, pp. 514–521

Publisher

Wolters Kluwer

Publication Date

October 1, 2011

DOI

10.1161/circinterventions.111.962142

ISSN

1941-7640

Contact the Experts team